Why the market is worried about Lilly's earnings but cautiously optimistic about housing stocks

Market Overview - Stocks declined on Tuesday, with the S&P 500 falling over 1% and the Nasdaq dropping approximately 2% due to a selloff in technology stocks [1] - Financial stocks, including Blue Owl Capital, KKR, Apollo Global Management, and BlackRock, also experienced declines as the market reacted to potential software losers from AI [1] Company-Specific Updates - Nvidia's stock fell more than 3% on Tuesday, maintaining a flat performance over the past six months; CEO Jensen Huang denied rumors of a fraying relationship with OpenAI during an interview with Jim Cramer [1] - Eli Lilly's shares dropped nearly 4% ahead of its earnings report, influenced by Novo Nordisk's disappointing guidance for 2026, which included a projected sales decline of 5% to 13% year over year [1] - Novo Nordisk's stock fell over 15% after announcing it expects lower sales in the U.S. due to price pressures and increasing competition, suggesting a potential loss of market share to Eli Lilly [1] Housing Market Insights - Housing-related stocks saw a rally following a report indicating efforts to make entry-level home buying more affordable, involving companies like Lennar and Taylor Morrison Home [1] - Despite the broader market decline, Home Depot's shares rose nearly 1%, indicating potential benefits from a revived housing market [1] Upcoming Earnings Reports - Key earnings reports expected after Tuesday's close include Advanced Micro Devices, Super Micro, Chipotle, Enphase Energy, Amgen, Amcor, Prudential Financial, Mondelez, and Corteva [1] - Notable reports before Wednesday's opening bell include GE Healthcare, Uber, Boston Scientific, Johnson Controls, AbbVie, Bunge, and Fortive [1]